Show simple item record

dc.contributor.advisorTello Hernández, Alejandro
dc.contributor.authorZambrano Ordoñez, José Daniel
dc.date.accessioned2020-06-26T20:01:42Z
dc.date.available2020-06-26T20:01:42Z
dc.date.issued2017
dc.identifier.urihttp://hdl.handle.net/20.500.12749/1785
dc.description.abstractLa hipertensión arterial es una patología muy importante en cuanto a que se considera un factor de riesgo cardiovascular muy relevante que conlleva a múltiples comorbilidades que comprometen diferentes órganos, sistemas y aparatos incluyendo al ojo. Por el hecho de ser una enfermedad sistémica, es uno de los contribuyentes prevenibles más importantes para desarrollar enfermedad y muerte.spa
dc.description.tableofcontents1. JUSTIFICACION 9 2. PLANTEAMIENTO DEL PROBLEMA 10 3. OBJETIVOS 11 3.1. OBJETIVO GENERAL 11 3.2. OBJETIVOS ESPECIFICOS 11 4. MARCO TEORICO 12 5. METODOLOGIA 22 5.1. TIPO DE ESTUDIO 22 5.2. POBLACION 22 5.3. CRITERIOS DE INCLUSION 22 5.4. CRITERIOS DE EXCLUSION 22 5.5. TAMAÑO DE LA MUESTRA 22 5.6. PROCEDIMIENTO 23 6. RESULTADOS 25 7. DISCUSION 32 8. BIBLIOGRAFIA 34
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titlePrevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamochaspa
dc.title.translatedPrevalence of hypertensive retinopathy in the Chicamocha cohort - Chicamocha sub studyeng
dc.degree.nameEspecialista en Oftalmología
dc.coverageBucaramanga (Santander, Colombia)
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNAB
dc.rights.localAbierto (Texto Completo)spa
dc.publisher.facultyFacultad Ciencias de la Salud
dc.publisher.programEspecialización en Oftalmología
dc.description.degreelevelEspecialización
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.localTesisspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.subject.keywordsHypertensive retinopathy
dc.subject.keywordsRetina
dc.subject.keywordsOcular hypertension
dc.subject.keywordsMedicine
dc.subject.keywordsOphthalmology
dc.subject.keywordsResearch
dc.subject.keywordsRetinal diseases
dc.subject.keywordsBlood pressure disorders
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNAB
dc.identifier.reponamereponame:Repositorio Institucional UNAB
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2
dc.relation.referencesZambrano Ordoñez, José Daniel (2017). Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha. Bucaramanga (Santander, Colombia) : Universidad Autónoma de Bucaramanga UNAB
dc.relation.references1. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365:217-23.
dc.relation.references2. Rogers AH. Hypertensive retinopathy, 113. In: Yanoff M, Duker JS, eds. Ophthalmology. 2nd ed. 2006;vol. 2:849e853.
dc.relation.references3. Tso MO, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology 1982;89(10):1132–45.
dc.relation.references4. Saitoh M, Matsuo K, Momoto S, KondohT, Yanagawa T, Katoh Y, Hasegawa K. Relationship between left ventricular hypertrophy and renal and retinal damage in untreated patients with essential hypertension Intern Med 1998;37(7):576-80.
dc.relation.references5. Daniels SR, Lipman MJ, Burke MJ, Loggie JM. Determinants of retinal vascular abnormalities in children and adolescents with essential hypertension. J Hum Hypertens. 1993;7(3):223-8
dc.relation.references6. Tso MO, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmol 1982; 89: 1132–45.
dc.relation.references7. Klein R, Sharrett AR, Klein BE, et al. Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol 2000; 20: 1644–50.
dc.relation.references8. Delles C, Michelson G, Harazny J, Oehmer S, Hilgers KF, Schmieder RE. Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke 2004; 35: 1289–93.
dc.relation.references9. Keith NM, Wagener HP, Barker NW. Some diff erent types of essential hypertension: their course and prognosis. Am J Med Sci 1974; 268: 336–45.
dc.relation.references10. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 2004; 351: 2310–17.
dc.relation.references11. Klein R, Klein BE, Moss SE, Wang Q. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol 1994; 112: 92–98.
dc.relation.references12. Yu T, Mitchell P, Berry G, Li W, Wang JJ. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 1998; 116: 83–89.
dc.relation.references13. Wong TY, Klein R, Klein BE, Meuer SM, Hubbard LD. Retinal vessel diameters and their associations with age and blood pressure.Invest Ophthalmol Vis Sci 2003; 44: 4644–50.
dc.relation.references14. Sharrett AR, Hubbard LD, Cooper LS, et al. Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999; 150: 263–70.
dc.relation.references15. Leung H, Wang JJ, Rochtchina E, Wong TY, Klein R, Mitchell P. Impact of current and past blood pressure on retinal arteriolar diameter in an older population. J Hypertens 2004; 22: 1543–49.
dc.relation.references16. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 2001; 358: 1134–40.
dc.relation.references17. Wong TY, Klein R, Nieto FJ, et al. Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmol 2003; 110: 933–40.
dc.relation.references18. Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR. Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 2005; 65: 1005–09.
dc.relation.references19. Wong TY, Rosamond W, Chang PP, et al. Retinopathy and risk of congestive heart failure. JAMA 2005; 293: 63–69.
dc.relation.references20. Wong TY, Coresh J, Klein R, et al. Retinal microvascular abnormalities and renal dysfunction: the atherosclerosis risk in communities study. J Am Soc Neph 2004; 15: 2469–76.
dc.relation.references21. Cuspidi C, Meani S, Salerno M, et al. Retinal microvascular changes and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22: 2095–102.
dc.relation.references22. Saitoh M, Matsuo K, Nomoto S, et al. Relationship between left ventricular hypertrophy and renal and retinal damage in untreated patients with essential hypertension. Int Med 1998; 37: 576–80.
dc.relation.references23. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634–40.
dc.relation.references24. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community. A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens. 2014;32:3–15.
dc.relation.references25. Morishita R, Higaki J, Nakamura F, et al. Regression of hypertension-induced vascular hypertrophy by an ACE inhibitor and calcium antagonist in the spontaneously hypertensive rat. Blood Pressure 1992; 3 (suppl): 41–47.
dc.relation.references26. Bock KD. Regression of retinal vascular changes by antihypertensive therapy. Hypertens 1984; 6: 158–62.
dc.relation.references27. Organización Mundial de la Salud. Información general sobre la hipertensión en el mundo. Una enfermedad que mata en silencio, una crisis de salud pública mundial. Ginebra (Suiza). 2013
dc.relation.references28. Grosso A, Veglio F, Porta M, Grignolo FM, Wong TY. Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol. 2005 Dec;89(12):1646-54.
dc.relation.references29. Yu T, Mitchell P, Berry G, Li W, Wang JJ. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol. 1998 Jan;116(1):83-9.
dc.relation.references30. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 2001; 358: 1134–40.
dc.relation.references31. Del Brutto OH, Mera RM, Viteri EM, Pólit J, Ledesma EA, Cano JA, et al. Hypertensive retinopathy and cerebral small vessel disease in Amerindians living in rural Ecuador: The Atahualpa Project. Int J Cardiol. 2016 Sep 1;218:65-68.
dc.relation.references32. Wong TY, Rosamond W, Chang PP, et al. Retinopathy and risk of congestive heart failure. JAMA 2005; 293: 63–69.
dc.contributor.cvlachttps://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0001009125
dc.contributor.googlescholarhttps://scholar.google.es/citations?hl=es#user=puxZHKYAAAAJ
dc.contributor.scopushttps://www.scopus.com/authid/detail.uri?authorId=6603664598
dc.subject.lembRetinopatía hipertensivaspa
dc.subject.lembRetinaspa
dc.subject.lembHipertensión ocularspa
dc.subject.lembMedicinaspa
dc.subject.lembOftalmologíaspa
dc.subject.lembInvestigacionesspa
dc.description.abstractenglishHypertension is a very important pathology in that it is considers a very relevant cardiovascular risk factor that leads to multiple comorbidities involving different organs, systems, and appliances including the eye. Due to the fact of being a systemic disease, it is one of the contributors preventable diseases to develop illness and death.eng
dc.subject.proposalEnfermedades de la retina
dc.subject.proposalTrastornos de la presión sanguínea
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 2.5 Colombia
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 2.5 Colombia